taxonomy (1)
protein (1)
source (3)
structure (4)
composition (23)
disease (1)
reference (3)
site (2)
peptide (6)
- Homo sapiens (Human)
Taxonomy
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
Reported structure
- Hex:3 HexNAc:4 NeuAc:1 (avg mass : 1608.4804 )
- Hex:3 HexNAc:4 NeuAc:2 (avg mass : 1899.7383 )
- Hex:4 HexNAc:3 NeuAc:1 (avg mass : 1567.4278 )
- Hex:4 HexNAc:3 dHex:2 (avg mass : 1568.4559 )
- Hex:4 HexNAc:4 NeuAc:1 (avg mass : 1770.6228 )
- Hex:4 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 1916.7658 )
- Hex:4 HexNAc:4 dHex:2 NeuAc:1 (avg mass : 2062.9088 )
- Hex:4 HexNAc:4 dHex:3 (avg mass : 1917.7939 )
- Hex:4 HexNAc:6 dHex:2 (avg mass : 2178.0409 )
- Hex:5 HexNAc:3 NeuAc:1 (avg mass : 1729.5702 )
- Hex:5 HexNAc:4 (avg mass : 1641.5073 )
- Hex:5 HexNAc:4 NeuAc:1 (avg mass : 1932.7652 )
- Hex:5 HexNAc:4 NeuAc:2 (avg mass : 2224.0231 )
- Hex:5 HexNAc:4 dHex:1 (avg mass : 1787.6503 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 2078.9082 )
- Hex:5 HexNAc:4 dHex:2 (avg mass : 1933.7933 )
- Hex:5 HexNAc:4 dHex:2 NeuAc:1 (avg mass : 2225.0512 )
- Hex:5 HexNAc:4 dHex:4
- Hex:5 HexNAc:6 dHex:1 (avg mass : 2194.0403 )
- Hex:6 HexNAc:4 NeuAc:1 (avg mass : 2094.9076 )
- Hex:6 HexNAc:4 dHex:1 (avg mass : 1949.7927 )
- Hex:6 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 2241.0506 )
- Hex:12 HexNAc:2 (avg mass : 2370.1141 )
Composition
- Cancer, breast (DOID:1612)
Disease
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Carbohydrate structure of human fibrinogen. Use of 300-MHz 1H-NMR to characterize glycosidase-treated glycopeptides. (1982 - Townsend RR, Hilliker E, Li Y-T, Laine RA, Bell WR, Lee YC) / Status : Reviewed
Reference
-
Fibrinogen beta chain / Homo sapiens
- Undefined site
- Asn-394
Reported glycosite
-
- N-Linked / Complex (avg mass : 1641.5073)
- Blood Plasma (UBERON_0001969)
-
Fibrinogen beta chain / Homo sapiens
- Undefined site
- Fibrinogen beta chain / Homo sapiens
-
- N-Linked / Complex (avg mass : 1932.7652)
- Blood Plasma (UBERON_0001969)
-
Fibrinogen beta chain / Homo sapiens
- Undefined site
- Fibrinogen beta chain / Homo sapiens
-
- N-Linked / Complex (avg mass : 1932.7652)
- Blood Plasma (UBERON_0001969)
-
Fibrinogen beta chain / Homo sapiens
- Undefined site
- Fibrinogen beta chain / Homo sapiens
-
- N-Linked / Complex (avg mass : 2224.0231)
- Blood Plasma (UBERON_0001969)
-
Fibrinogen beta chain / Homo sapiens
- Undefined site
- Fibrinogen beta chain / Homo sapiens
-
- Hex:4 HexNAc:3 NeuAc:1 / N-Linked (avg mass : 1567.4278)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibrinogen beta chain / Homo sapiens
- GTAGNAIMDGASQIMGENR (19aa)
-
- Hex:4 HexNAc:3 dHex:2 / N-Linked (avg mass : 1568.4559)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibrinogen beta chain / Homo sapiens
- GTAGNAIMDGASQIMGENR (19aa)
-
- Hex:3 HexNAc:4 NeuAc:1 / N-Linked (avg mass : 1608.4804)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibrinogen beta chain / Homo sapiens
- GTAGNAIMDGASQIMGENR (19aa)
-
- Hex:5 HexNAc:4 / N-Linked (avg mass : 1641.5073)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibrinogen beta chain / Homo sapiens
- GTAGNAIMDGASQIMGENR (19aa)
-
- Hex:5 HexNAc:3 NeuAc:1 / N-Linked (avg mass : 1729.5702)
- Blood Serum (UBERON_0001977)
- Fibrinogen beta chain / Homo sapiens
- YRGTAGNALMDGASQLMGENR (21aa)
-
- Hex:4 HexNAc:4 NeuAc:1 / N-Linked (avg mass : 1770.6228)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibrinogen beta chain / Homo sapiens
- GTAGNAIMDGASQIMGENR (19aa)
-
- Hex:5 HexNAc:4 dHex:1 / N-Linked (avg mass : 1787.6503)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibrinogen beta chain / Homo sapiens
- GTAGNAIMDGASQIMGENR (19aa)
-
- Hex:3 HexNAc:4 NeuAc:2 / N-Linked (avg mass : 1899.7383)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibrinogen beta chain / Homo sapiens
- GTAGNAIMDGASQIMGENR (19aa)
-
- Hex:4 HexNAc:4 dHex:1 NeuAc:1 / N-Linked (avg mass : 1916.7658)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibrinogen beta chain / Homo sapiens
- GTAGNAIMDGASQIMGENR (19aa)
-
- Hex:4 HexNAc:4 dHex:3 / N-Linked (avg mass : 1917.7939)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibrinogen beta chain / Homo sapiens
- GTAGNAIMDGASQIMGENR (19aa)
-
- Hex:5 HexNAc:4 NeuAc:1 / N-Linked (avg mass : 1932.7652)
- Cancer, breast (DOID:1612)
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Fibrinogen beta chain / Homo sapiens
- YRGTAGNALMDGASQLMGENR (21aa)
- ALMDGASQLMGENR (14aa)
- GTAGNALMDGASQLMGENR (19aa)
- GTAGNAIMDGASQIMGENR (19aa)
- MDGASQLMGENR (12aa)
-
- Hex:5 HexNAc:4 dHex:2 / N-Linked (avg mass : 1933.7933)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibrinogen beta chain / Homo sapiens
- GTAGNAIMDGASQIMGENR (19aa)
-
- Hex:6 HexNAc:4 dHex:1 / N-Linked (avg mass : 1949.7927)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibrinogen beta chain / Homo sapiens
- YRGTAGNALMDGASQLMGENR (21aa)
- GTAGNAIMDGASQIMGENR (19aa)
-
- Hex:4 HexNAc:4 dHex:2 NeuAc:1 / N-Linked (avg mass : 2062.9088)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibrinogen beta chain / Homo sapiens
- GTAGNAIMDGASQIMGENR (19aa)
-
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 / N-Linked (avg mass : 2078.9082)
- Cancer, breast (DOID:1612)
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Fibrinogen beta chain / Homo sapiens
- DGASQLMGENR (11aa)
- GTAGNAIMDGASQIMGENR (19aa)
-
- Hex:6 HexNAc:4 NeuAc:1 / N-Linked (avg mass : 2094.9076)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibrinogen beta chain / Homo sapiens
- GTAGNAIMDGASQIMGENR (19aa)
-
- Hex:4 HexNAc:6 dHex:2 / N-Linked (avg mass : 2178.0409)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibrinogen beta chain / Homo sapiens
- GTAGNAIMDGASQIMGENR (19aa)
-
- Hex:5 HexNAc:4 dHex:4 / N-Linked
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibrinogen beta chain / Homo sapiens
- GTAGNAIMDGASQIMGENR (19aa)
-
- Hex:5 HexNAc:6 dHex:1 / N-Linked (avg mass : 2194.0403)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibrinogen beta chain / Homo sapiens
- GTAGNAIMDGASQIMGENR (19aa)
-
- Hex:5 HexNAc:4 NeuAc:2 / N-Linked (avg mass : 2224.0231)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibrinogen beta chain / Homo sapiens
- YRGTAGNALMDGASQLMGENR (21aa)
- ALMDGASQLMGENR (14aa)
- GTAGNAIMDGASQIMGENR (19aa)
-
- Hex:5 HexNAc:4 dHex:2 NeuAc:1 / N-Linked (avg mass : 2225.0512)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibrinogen beta chain / Homo sapiens
- GTAGNAIMDGASQIMGENR (19aa)
-
- Hex:6 HexNAc:4 dHex:1 NeuAc:1 / N-Linked (avg mass : 2241.0506)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibrinogen beta chain / Homo sapiens
- YRGTAGNALMDGASQLMGENR (21aa)
- GTAGNAIMDGASQIMGENR (19aa)
-
- Hex:12 HexNAc:2 / N-Linked (avg mass : 2370.1141)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibrinogen beta chain / Homo sapiens
- GTAGNAIMDGASQIMGENR (19aa)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
